Advertisement
News
Subscribe to MDT Magazine News

Medtronic 4Q profit drops on job-cutting expenses

May 24, 2011 3:45 am | by The Associated Press | Comments

Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.The Minneapolis-based company earned $776 million, or 72 cents per share, down from $954 million, or 86 cents per share, a year ago. Excluding...

Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

May 24, 2011 3:34 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

TOPICS:

Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

May 24, 2011 3:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017...

TOPICS:
Advertisement

Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis

May 24, 2011 2:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis...

TOPICS:

Boston Heart Lab Changes Name to Boston Heart Diagnostics

May 24, 2011 2:32 am | by Bio-Medicine.Org | Comments

FRAMINGHAM, Mass., May 24, 2011 /- Framingham-based Boston Heart Lab announced that it is changing its name to Boston Heart Diagnostics. The company launched its new name and logo at the National Lipid Association Scientific Sessions conference, held May 19-22 in New York City. (Logo:...

TOPICS:

Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides

May 24, 2011 1:34 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Leukemia, Lymphoma and Peptides...

TOPICS:

Prometheus Announces Agreement to be Acquired by Nestle Health Science

May 23, 2011 11:32 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, May 24, 2011 /- Prometheus Laboratories Inc., ("Prometheus") a specialty pharmaceutical and diagnostic company, today announced that it has entered into a definitive agreement to be acquired by Nestle Health Science S.A., a wholly-owned subsidiary of Nestle S.A., for an...

TOPICS:

EndyMed Announces the World's First 3DEEP RF Skin Tightening and Fractional Skin Resurfacing Combined Treatment Platform

May 23, 2011 12:35 pm | by Bio-Medicine.Org | Comments

CAESAREA, Israel, May 23, 2011 /- EndyMed Medical, Ltd., www.endymed.com , a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today that the results of a new study will be presented at the upcoming 22nd World Congress of Dermatology, in...

TOPICS:
Advertisement

VTI?s 3D MEMS technology: small size, high quality and low power sensors for healthcare devices

May 23, 2011 11:36 am | by I-Micronews | Comments

Healthcare applications account for approximately 15% of the total value of the MEMS (Micro Electro Mechanical Systems) market, and it is expected that the figure will rise to 25% by the year 2015.

Analog devices' IMEMS dual-axis accelerometer delivers guaranteed high temperature operation up to +175° c

May 23, 2011 11:35 am | by I-Micronews | Comments

ADI?s ADXL206 iMEMS® accelerometer measures acceleration with a full-scale range of ±5 g with 1 mg resolution and a temperature range of -40° C to +175° C.

Beckman Coulter, Inc., Synchron LX Clinical Systems Ion Selective Electrolyte (ISE) Flow Cell: Class I Recall - Incorrect Electrolyte Results

May 23, 2011 11:30 am | by U.S. Food & Drug Administration | Comments

Errors may be the result of ratio pump wear, silver iodide build-up on the chloride electrode, microbial contamination, and instrument maintenance.

TOPICS:

AstraZeneca, Biogen look externally for new drug candidates

May 23, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

AstraZeneca Plc and Biogen Idec Inc. have joined the ranks of local large biotech and pharmaceutical companies like Pfizer Inc., which, facing looming patent expirations and unproductive pipelines, are reaching outside their own walls to find new drug candidates.

TOPICS:

Pentrexyl Forte Natural: Recall - Misleading Packaging

May 23, 2011 10:30 am | by U.S. Food & Drug Administration | Comments

Dietary supplement product packaging may cause it to be confused with an antibiotic product.

TOPICS:

FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration

May 23, 2011 9:35 am | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y. May 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that it has scheduled a Dermatologic and Ophthalmic Drugs Advisory Committee Meeting to be held on June 17, 2011 to...

TOPICS:

Heska to Present at SunTrust Robinson Humphrey's Annual Veterinary and Dental Conference

May 23, 2011 9:33 am | by Bio-Medicine.Org | Comments

LOVELAND, Colo., May 23, 2011 /- Heska Corporation (NASDAQ: HSKA ) today announced it will present at the SunTrust Robinson Humphrey Annual Veterinary and Dental Conference on Wednesday, June 1, 2011.  The presentation will be at the Le Parker Meridien Hotel at 119 West 56th Street...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading